Basepoint Wealth’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$433K Sell
5,669
-1,521
-21% -$110K 0.25% 64
2025
Q4
$459K Sell
7,190
-290
-4% -$17.9K 0.28% 57
2025
Q3
$472K Sell
7,480
-515
-6% -$35.9K 0.33% 57
2025
Q2
$597K Sell
7,995
-704
-8% -$55.3K 0.46% 45
2025
Q1
$766K Sell
8,699
-519
-6% -$49K 0.6% 30
2024
Q4
$842K Buy
9,218
+352
+4% +$36.1K 0.67% 33
2024
Q3
$993K Sell
8,866
-215
-2% -$21.5K 0.73% 28
2024
Q2
$890K Sell
9,081
-81
-0.9% -$8.04K 0.7% 29
2024
Q1
$918K Sell
9,162
-35
-0.4% -$3.08K 0.69% 34
2023
Q4
$826K Sell
9,197
-424
-4% -$33.8K 0.66% 39
2023
Q3
$738K Buy
9,621
+41
+0.4% +$3.4K 0.6% 39
2023
Q2
$802K Buy
9,580
+10
+0.1% +$813 0.66% 40
2023
Q1
$807K Buy
9,570
+115
+1% +$9.88K 0.67% 38
2022
Q4
$770K Buy
9,455
+1,434
+18% +$116K 0.68% 41
2022
Q3
$570K Buy
8,021
+2,372
+42% +$213K 0.61% 45
2022
Q2
$507K Buy
+5,649
New +$585K 0.53% 49

Other funds holding EMN

Basepoint Wealth's EMN Position: Q1 2026 in Review

Basepoint Wealth reduced its Eastman Chemical (EMN) stake by 21% in Q1 2026, selling an estimated $110K and leaving 5,669 shares worth $433K. The position accounts for 0.25% of the portfolio, ranked #64.

Basepoint Wealth first reported a position in EMN in Q2 2022 and has held it in 16 quarters since. The position peaked at $993K in Q3 2024. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Basepoint Wealth held 5,669 shares of Eastman Chemical worth $433K as of Q1 2026.
  • Basepoint Wealth sold 1,521 Eastman Chemical shares in Q1 2026, an estimated $110K.
  • Eastman Chemical made up 0.25% of Basepoint Wealth's portfolio in Q1 2026, its #64 holding.
  • Basepoint Wealth first reported a position in Eastman Chemical in Q2 2022 and has held it in 16 quarters since.
  • Basepoint Wealth's Eastman Chemical position peaked at $993K in Q3 2024.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.